Arcus biosciences to participate in two upcoming investor conferences

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that its management team will participate in the following upcoming investor conferences in december: evercore 7th annual healthconx conference date: tuesday, december 3rd, 2024 location: coral gables, fl format: fireside chat & 1x1 meetings time: 7:55 a.m. et citi 2024.
RCUS Ratings Summary
RCUS Quant Ranking